Clinical Trial Details

Trial ID: L0518
Source ID: IRCT20161205031252N4
Associated Drug: Phlebotomy
Title: Study of phlebotomy efficacy in improvement of liver fibrosis and its function among patients with non alcoholic steatohepatitis
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic steatohepatitis (NASH). <br>Other specified inflammatory liver diseases;Other specified inflammatory liver diseases
Interventions: Intervention 1: Intervention group: Phlebotomy at first and fifth months, (with a needle and a blood transfusion bag, 400 cc each time from the median cubital vein) with routine treatment. Intervention 2: Control group: Routine treatment.;Treatment - Othe
Outcome Measures: Liver fibrosis. Timepoint: before intervention and after 6 month. Method of measurement: fibroscan.;Liver function. Timepoint: before intervention and after 6 month. Method of measurement: Blood samples laboratory study.Ferritin level. Timepoint: at the begining of study and 6 months later. Method of measurement: Laboratory blood level measurement.
Sponsor/Collaborators: Ghoum University of Medical Sciences
Gender: All
Age: 18 years65 years
Phases: Not applicable
Enrollment: 40
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: block randomization, Unit of randomization:individual, Blinding description: Care provider is blinded.
Start Date: 06/12/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/24632